PLUR
Pluri Inc.
Key Financials
Revenue
$1.3M
↑ 309.8%
Operating Income
$-22176000
↓ 0.1%
Gross Profit
$654000
↑ 103.1%
Shareholders' Equity
$-6842000.00
↓ 7227.1%
Total Assets
$38.7M
↓ 2.1%
Net Income
$-22583000
↓ 8.1%
EPS (Diluted)
$-3.56
↑ 10.8%
Cash & Equivalents
$5.9M
↓ 13.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 7/1/2026 | View on SEC |
| SCHEDULE 13D/A | 7/1/2026 | View on SEC |
| 8-K | 6/22/2026 | View on SEC |
| 8-K | 6/1/2026 | View on SEC |
| 10-Q | 5/14/2026 | View on SEC |
| 4 | 5/4/2026 | View on SEC |
| SCHEDULE 13D/A | 5/1/2026 | View on SEC |
| ARS | 4/23/2026 | View on SEC |
| DEFA14A | 4/23/2026 | View on SEC |
| DEF 14A | 4/23/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PLUR |
| Company Name | Pluri Inc. |
| CIK | 1158780 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | NV |
| Phone | 972-74-710-7171 |